Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |